Pieris Pharmaceuticals Inc. | Key People and Executives
Stephen S. Yoder
President, Chief Executive Officer & Director
Peter Alec Kiener
Director
James A. Geraghty
Chairman
Ann Barbier
Independent Director
Christopher P. Kiritsy
Independent Director
Jean-Pierre Bizzari
Independent Director
Steven Prelack
Independent Director
Michael S. Richman
Independent Director
Stephen S. Yoder
President, Chief Executive Officer & Director
Allan Jacob Reine
Treasurer, Chief Financial & Accounting Officer
Louis A. Matis
Chief Development Officer & Senior VP
Ingmar Bruns
Vice President-Clinical Development
Eckhard Niemeier
Vice President & Head-Business Development
Peter Alec Kiener
Director
Claus Schalper
Co-Founder
Maria Kelman
Director-Investor Relations
Frank Vollmering
Vice President-Human Resources
Ahmed S. Mousa
Secretary, VP-Licensing, IP & Legal Affairs
James A. Geraghty
Chairman
Ann Barbier
Independent Director
Christopher P. Kiritsy
Independent Director
Jean-Pierre Bizzari
Independent Director
Steven Prelack
Independent Director
Michael S. Richman
Independent Director
| Address |
255 State Street
Boston Massachusetts 02109
United States
|
|
Employees
|
- |
| Website |
http://www.pieris.com |
| Updated |
07/08/2019 |
| Pieris Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. It offers technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with an unmet medical need. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA. |
